ACAD
Price
$28.98
Change
+$0.05 (+0.17%)
Updated
Sep 3, 10:37 AM (EDT)
Capitalization
4.99B
69 days until earnings call
Intraday BUY SELL Signals
SANA
Price
$3.89
Change
+$0.06 (+1.57%)
Updated
Sep 2 closing price
Capitalization
1.17B
63 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACAD vs SANA

ACAD vs SANA Comparison Chart in %
View a ticker or compare two or three
VS
ACAD vs. SANA commentary
Sep 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a Hold and SANA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2026
Stock price -- (ACAD: $28.93 vs. SANA: $3.89)
Brand notoriety: ACAD and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 102% vs. SANA: 82%
Market capitalization -- ACAD: $4.99B vs. SANA: $1.17B
ACAD [@Biotechnology] is valued at $4.99B. SANA’s [@Biotechnology] market capitalization is $1.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $141.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 1 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • ACAD’s FA Score: 1 green, 4 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACAD and SANA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 4 TA indicator(s) are bullish while SANA’s TA Score has 4 bullish TA indicator(s).

  • ACAD’s TA Score: 4 bullish, 5 bearish.
  • SANA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ACAD is a better buy in the short-term than SANA.

Price Growth

ACAD (@Biotechnology) experienced а -2.20% price change this week, while SANA (@Biotechnology) price change was -6.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.86%. For the same industry, the average monthly price growth was +5.40%, and the average quarterly price growth was +2515.71%.

Reported Earning Dates

ACAD is expected to report earnings on Nov 11, 2026.

SANA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-2.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACAD($4.99B) has a higher market cap than SANA($1.17B). ACAD YTD gains are higher at: 8.311 vs. SANA (-4.423). ACAD has higher annual earnings (EBITDA): 92.7M vs. SANA (-192.2M). ACAD has more cash in the bank: 851M vs. SANA (101M). ACAD has less debt than SANA: ACAD (50.8M) vs SANA (75.3M). ACAD has higher revenues than SANA: ACAD (1.1B) vs SANA (0).
ACADSANAACAD / SANA
Capitalization4.99B1.17B427%
EBITDA92.7M-192.2M-48%
Gain YTD8.311-4.423-188%
P/E Ratio12.98N/A-
Revenue1.1B0-
Total Cash851M101M843%
Total Debt50.8M75.3M67%
FUNDAMENTALS RATINGS
ACAD: Fundamental Ratings
ACAD
OUTLOOK RATING
1..100
39
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
26
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACADSANA
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ACAD
Daily Signal:
Gain/Loss:
SANA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
URSP51.060.40
+0.79%
ProShares Ultra S&P 500 Equal Weight
SFTX31.220.20
+0.65%
Horizon International Managed Risk ETF
SCHP25.82N/A
N/A
Schwab US TIPS ETF™
WTMU25.09-0.01
-0.05%
WisdomTree Core Laddered Municipal
SPRE20.52-0.14
-0.68%
SP Funds S&P Global REIT Sharia ETF